U.S. Physical Therapy, Inc.

NYSE:USPH

Medical - Care Facilities

Healthcare
$95.43 +0.19%

+$0.12 today

Market cap
$1.42B
Beta
1.16
P/E (TTM)
810.7
EPS (TTM)
$0.08
Dividend yield
2.89%
52W Low $58.19High $93.50

Volume 0.33M

Average 0.20M

USPH Accounts Receivables

Cash effect of the change in amounts owed by customers; growing receivables consume cash.

U.S. Physical Therapy, Inc.NYSE: USPH

Accounts Receivables · Q1 FY2026 · quarter ended Mar 2026

Accounts receivables grows, but more slowly than its trailing trend

Q1 FY2026 accounts receivables of $8.48M (cash outflow) rose 15.6% year over year, behind the +206.8% change in trailing-twelve-month accounts receivables. Over 3 fiscal years it compounded at -4.1% a year.

Context

  • Accounts receivables amounted to 1.2% of revenue in FY2025, down 0.6 pp from a year earlier.
  • Accounts receivables grew in size in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from +15.6% toward the trailing-twelve-month pace of +206.8%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$8.48M-961.2% QoQ
Last fiscal yearDec 2025
-$9.06M-23.8% YoY
LTMMar 2026
-$10.98M+206.8% YoY
Accounts Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+15.6%——
1 year-23.8%——
3-year CAGR-4.1%——
5-year CAGR——
10-year CAGR——

Accounts Receivables history

USD · from the cash flow

Latest · FY2025
(9.06M) USD
Year-over-year change
+23.8%

Accounts Receivables vs competitors

How USPH compares with its peers on the latest reported figures

  • USPH's LTM Mar 2026 accounts receivables of $10.98M is the 5th largest of the 11 companies compared; the peer median is $5.86M.
  • Its year-over-year change of +206.8% is the 3rd highest of 10, against a peer median of -100.0%.
  • Accounts receivables amounts to 1.5% of revenue for USPH, versus a peer median of 0.8%.
USPH Competitors Peer median
Accounts Receivables for USPH and competitors
Company Period LTM YoY 3-year CAGR% of revenue
GDRXGoodRx Holdings, Inc.LTM Mar 2026$70.81M +361.4%—9.0%
SEMSelect Medical Holdings CorporationLTM Mar 2026$45.19M -535.3%-4.7%0.8%
AHCOAdaptHealth Corp.LTM Apr 2026$25.35M +2637.1%—0.9%
HCSGHealthcare Services Group, Inc.LTM Mar 2026$12.18M -148.1%—0.7%
USPHU.S. Physical Therapy, Inc.LTM Mar 2026$10.98M +206.8%-4.1%1.5%
PNTGThe Pennant Group, Inc.LTM Mar 2026$10.3M -57.9%+305.9%1.0%
KMTSKestra Medical Technologies, Ltd.LTM Jan 2026$8.99M +37.6%—10.7%
CNMDCONMED CorporationLTM Mar 2026$2.74M -115.0%-23.2%0.2%
NEOGNeogen CorporationLTM Aug 2026$407K -101.7%—0.0%
ZBIOZenas BioPharma, Inc.LTM Mar 2026$0 ———
ASTHAstrana Health, Inc.LTM Mar 2026$0 -100.0%-40.5%0.0%
Peer median (excluding USPH) $5.86M-100.0%-13.9%0.8%

Competitors are the stored peer set for USPH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income57.92M43.41M37.22M45.6M58.01M
Depreciation & Amortization11.59M14.74M15.7M18.68M22.39M
Deferred Income Tax5.69M4.31M4.49M5.37M11.41M
Stock-Based Compensation7.87M7.26M7.24M7.82M8.27M
Change in Working Capital(11.78M)(21.43M)(4.93M)(12.4M)(27.19M)
Accounts Receivables(10.96M)(10.28M)(6M)(11.89M)(9.06M)
Inventory00000
Accounts Payables0(7.76M)15K0(7.8M)
Other Working Capital(824K)(3.4M)1.06M(510K)(10.33M)
Other Non-Cash Items5.12M10.24M22.27M9.88M2.18M
Operating Cash Flow76.41M58.54M81.98M74.94M75.06M
Capital Expenditures(8.2M)(8.25M)(9.29M)(9.19M)(14.07M)
Acquisitions (Net)(116.09M)(74.28M)(36.87M)(142.04M)(24.95M)
Purchases of Investments0(373K)000
Sales of Investments0373K000
Other Investing Activities152K1.26M1.15M1.77M2.31M
Investing Cash Flow(124.14M)(81.27M)(45.02M)(149.45M)(36.71M)
Debt Repayment93.1M64.2M(39.15M)4.3M8.06M
Common Stock Issued00163.65M00
Common Stock Repurchased0000(5.57M)
Dividends Paid(18.77M)(21.32M)(24.13M)(26.54M)(27.36M)
Other Financing Activities(30.96M)(17.12M)(16.1M)(14.71M)(19.27M)
Financing Cash Flow43.38M25.76M84.27M(36.95M)(44.14M)
Effect of Forex Changes00000
Net Change in Cash(4.35M)3.03M121.23M(111.46M)(5.79M)
Free Cash Flow68.21M50.29M72.68M65.75M60.99M

U.S. Physical Therapy, Inc.

NYSE:USPH

Intrinsic Alpha fair value

Locked

Current Price

$95.43

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.